# Monopar Therapeutics: Form 8-K, filed May 13, 2025

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 8-K
- Filed: 2025-05-13
- Accepted by EDGAR: May 13, 2025, 12:00 ET
- Period: 2025-05-13
- Accession: 0001437749-25-016262
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774925016262/mnpr20250508_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774925016262/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774925016262/mnpr20250508_8k.htm

Filed May 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-016262. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.